Financials
- Market Capitalization 27.19 B
- Employee 100
- Founded 1996
- CEO N/A
- Website www.royaltypharma.com
- Headquarter United Kingdom
- FIGI N/A
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
21.71
Relación precio/flujo de caja
9.17
Dividendos por acción
0.88
Rendimiento por dividendo, %
2.28
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 347 | RVMD Revolution Medicines, Inc. - Common Stock | 206.30 USD | -6.71% | -1.24% | +12.00% | +272.38% | 44.22 B USD | ||
| 445 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 237.74 USD | +0.50% | -0.03% | -17.41% | -47.47% | 31.81 B USD | ||
| 503 | ROIV Roivant Sciences Ltd. - Common Shares | 35.57 USD | -5.35% | -2.89% | +4.96% | +94.27% | 25.69 B USD | ||
| 510 | INSM Insmed Incorporated - Common Stock | 118.64 USD | -2.27% | -6.41% | +14.10% | -26.79% | 25.91 B USD |